Awatef Ben Jemaa

Bizerte, 7021, Tunisia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia.

Comparison of long-term anti-RBD SARS-CoV-2 antibody response following different vaccination schemes in Tunisia.

Journal: La Tunisie medicale
Published: March 21, 2024

Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD.

Immunometabolism mRNA expression phenotypes and reprogramming of CD14 in T2DM with or without CVD.

Journal: International immunopharmacology
Published: February 06, 2023

Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.

Evaluation of individual and combined NLR, LMR and CLR ratio for prognosis disease severity and outcomes in patients with COVID-19.

Journal: International immunopharmacology
Published: February 26, 2022

PSMA-PSA clones controlled by full Akt phosphorylation (T308+,S473+) recapitulate molecular features of human prostate cancer.

PSMA-PSA clones controlled by full Akt phosphorylation (T308+,S473+) recapitulate molecular features of human prostate cancer.

Journal: La Tunisie medicale
Published: January 28, 2016

Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences.

Insight into the heterogeneity of prostate cancer through PSA-PSMA prostate clones: mechanisms and consequences.

Journal: Histology and histopathology
Published: May 03, 2014

Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.

Cellular distribution and heterogeneity of Psa and Psma expression in normal, hyperplasia and human prostate cancer.

Journal: La Tunisie medicale
Published: September 07, 2013

PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.

PSA-PSMA profiles and their impact on sera PSA levels and angiogenic activity in hyperplasia and human prostate cancer.

Journal: Pathologie-biologie
Published: April 29, 2013

A comparison of the biological features of prostate cancer with (PSA+, PSMA+) profile according to RKIP.

A comparison of the biological features of prostate cancer with (PSA+, PSMA+) profile according to RKIP.

Journal: BioMed research international
Published: April 20, 2013

The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

Journal: Inflammation
Published: December 20, 2012

A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.

A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.

Journal: Cell biology international
Published: November 16, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026